Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Hepatitis B virus infection.

Lee WM.

N Engl J Med. 1997 Dec 11;337(24):1733-45. Review. No abstract available.

PMID:
9392700
[PubMed - indexed for MEDLINE]
2.
3.

Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.

Kruger M, Böker KH, Zeidler H, Manns MP.

J Hepatol. 1997 Apr;26(4):935-9.

PMID:
9126810
[PubMed - indexed for MEDLINE]
4.

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.

N Engl J Med. 1999 Jul 1;341(1):22-6.

PMID:
10387938
[PubMed - indexed for MEDLINE]
Free Article
5.

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

Chu CJ, Lee SD.

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x. No abstract available.

PMID:
20136983
[PubMed - indexed for MEDLINE]
6.

Treatment of hepatitis B virus-associated nephropathy in black children.

Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC.

Pediatr Nephrol. 2002 Jun;17(6):393-9.

PMID:
12107801
[PubMed - indexed for MEDLINE]
7.

The impact of previous HBV infection on the course of chronic hepatitis C.

De Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, Harig J, Van Thiel DH.

Am J Gastroenterol. 2000 Dec;95(12):3529-36.

PMID:
11151889
[PubMed - indexed for MEDLINE]
8.

Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.

Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP.

Z Gastroenterol. 2007 Dec;45(12):1281-328. No abstract available.

PMID:
18080231
[PubMed - indexed for MEDLINE]
9.

Antiviral therapy in hepatitis B infection.

Thomas HC, Scully LJ.

Br Med Bull. 1985 Oct;41(4):374-80. Review. No abstract available.

PMID:
3902143
[PubMed - indexed for MEDLINE]
10.

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.

Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Häussinger D.

N Engl J Med. 1996 May 30;334(22):1422-7.

PMID:
8618580
[PubMed - indexed for MEDLINE]
Free Article
11.

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.

Chen LW, Chien RN, Yen CL, Chang JJ, Liu CJ, Lin CL.

J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.

PMID:
19817959
[PubMed - indexed for MEDLINE]
12.

Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.

Craxì A, Di Marco V, Volpes R, Marra S, Rizzetto M, Rosina F, Barbera C, Bortolotti F, Crivellaro C, Iannuzzi C, et al.

Prog Clin Biol Res. 1991;364:399-404. No abstract available.

PMID:
2020715
[PubMed - indexed for MEDLINE]
13.

Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.

Günther S, Meisel H, Reip A, Miska S, Krüger DH, Will H.

Virology. 1992 Mar;187(1):271-9.

PMID:
1736529
[PubMed - indexed for MEDLINE]
14.

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

Ferraro D, Bonura C, Giglio M, Di Stefano R, Almasio PL, Di Marco V, Craxì A, Cacciola I, Squadrito G, Raimondo G.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.

PMID:
14518718
[PubMed - indexed for MEDLINE]
15.

Treatment of HBV-related liver disease in the dialysis population: reality and promises.

Fabrizi F, Lunghi G, Martin P.

Int J Artif Organs. 2001 Sep;24(9):598-605. Review. No abstract available.

PMID:
11693415
[PubMed - indexed for MEDLINE]
16.

Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.

Marinos G, Naoumov NV, Rossol S, Torre F, Wong PY, Gallati H, Portmann B, Williams R.

Gastroenterology. 1995 May;108(5):1453-63.

PMID:
7729638
[PubMed - indexed for MEDLINE]
17.

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, de Lalla F, Webster GJ, Dusheiko G.

J Clin Virol. 2004 Mar;29(3):160-6.

PMID:
14962784
[PubMed - indexed for MEDLINE]
18.

Hepatitis B.

Befeler AS, Di Bisceglie AM.

Infect Dis Clin North Am. 2000 Sep;14(3):617-32. Review.

PMID:
10987113
[PubMed - indexed for MEDLINE]
19.

Prevention and treatment of virus hepatitis B.

Sherlock S.

Indian J Gastroenterol. 1984 Jan;3(1):29-31. Review. No abstract available.

PMID:
6241924
[PubMed - indexed for MEDLINE]
20.

Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.

Han HL, Lang ZW.

World J Gastroenterol. 2003 Jan;9(1):117-21.

PMID:
12508364
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk